Revolution Medicines Officer Files Form 144 to Sell $802K in Common Stock
Revolution Medicines, Inc.
Subscribe to track RVMD
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Form 144 Notice of Proposed Sale of Securities Issuer: Revolution Medicines, Inc. ($RVMD) Filer: Jack Anders (Officer) Shares to Sell: 3,939 Common Stock Aggregate Market Value: $802,650.03 Approximate Sale Date: September 15, 2026 Acquisition Source: RSU Vesting (September 15, 2026) Rule 10b5-1 Plan Adoption Date: May 31, 2023
Comprehensive Analysis
Executive Summary
On September 15, 2026, Jack Anders, an Officer at Revolution Medicines, Inc. (NASDAQ: RVMD), filed SEC Form 144 proposing the sale of 3,939 shares of Common Stock with an estimated aggregate market value of $802,650.03.
Transaction Details
- Security: Common Stock
- Number of Shares: 3,939
- Aggregate Value: $802,650.03 (~$203.77 per share)
- Broker: ETRADE Financial Corporation
- Source of Acquisition: Acquired via RSU vesting on September 15, 2026, as compensation for services rendered.
- Trading Plan: Executed pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2023.
Prior Sales in Past 3 Months
- June 24, 2026: 20,000 shares sold for gross proceeds of $3,366,604.46.
- June 16, 2026: 2,722 shares sold for gross proceeds of $424,956.46.
Market Impact & Significance
This transaction represents a routine disposition tied to equity compensation vesting under a long-standing Rule 10b5-1 plan. Given the modest transaction volume relative to the company's 214.3 million shares outstanding, market impact is anticipated to be negligible.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.